2nd Clinical Site for Gene Therapy Trial for Usher Syndrome
July 26, 2012
The Foundation Fighting Blindness and Oxford BioMedica announced funding for a second clinical site to conduct a gene therapy trial for Ushers Syndrome. The site will be the Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts in Paris, and will join the ongoing clinical trial being held at the Oregon Health & Science University’s Casey Eye Institute.
To read all of the details, please follow this link.
You might also enjoy...
- Gene Therapy Trial for Retinitis Pigmentosa Based on Usher’s Syndrome To Begin
- Stem Cells Inc. Gets FDA Authorization to Initiate Clinical Trial to Use Human Neural Stem Cells to Treat Dry AMD
- ACT Adds Third Clinical Trial Site for Testing Treatment of Dry Macular Degeneration With Embryonic Stem Cells
- A Complete List of Current Ophthalmic Stem Cell Trials
- Can Gene Therapy Help Treat Usher Syndrome Patients with Retinitis Pigmentosa?
Jump down to form below to submit your own comments